Human Serum Amyloid P (APCS) ELISA KIT (1 x 96 wells)
CAT#: EA102393
For quantitative detection of human SAP in cell culture supernates, cell lysates, serum and plasma (heparin, EDTA).
CNY 5,000.00
货期*
3周
规格
Cited in 1 publication. |
Product images
Specifications
Product Data | |
Description | For quantitative detection of human SAP in cell culture supernates, cell lysates, serum and plasma (heparin, EDTA). |
Size | 1 x 96 wells |
Format | 8x12 divisible strips |
Assay Type | Sandwich ELISA kit of Quantitative Detection for human SAP |
Assay Length | 3.5 hours incubations; 1 hour washing and analyzing samples |
Signal | Colorimetric |
Curve Range | 1.56ng/ml-100ng/ml |
Specificity | This kit is used for quantitative detection of human SAP |
Sensitivity | <10pg/ml |
Reactivity | Human |
Cross Reactivity | There is no detectable cross-reactivity with other relevant proteins |
Components |
|
Background | Amyloid P component, serum (SAP), also known as PTX2 or APCS, is the identical serum form of amyloid P component (AP), a 25kDa pentameric protein first identified as the pentagonal constituent of in vivo pathological deposits called "amyloid". It belongs to the pentraxins family, characterised by calcium dependent ligand binding and distinctive flattened β-jellyroll structure similar to that of the legume lectins. This gene is mapped to 1q23.2. The binding of the encoded protein to proteins in the pathological amyloid cross-beta fold suggests its possible role as a chaperone. This protein is also thought to control the degradation of chromatin. It has been demonstrated that this protein binds to apoptotic cells at an early stage, which raises the possibility that it is involved in dealing with apoptotic cells in vivo. |
Gene Symbol | APCS |
Citations (1)
The use of this Assay Kits has been cited in the following citations: |
---|
Liver-specific deletion of Eva1a/Tmem166 aggravates acute liver injury by impairing autophagy
,null,
Cell Death & Disease
,PubMed ID 29991758
[APCS]
|
Documents
Product Manuals |
Customer
Reviews
Loading...